Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome
Status:
Completed
Trial end date:
2015-08-26
Target enrollment:
Participant gender:
Summary
The primary aim is to test the reduction of bone marrow edema syndrome after a singular
intravenous treatment with Zoledronic Acid within 6 weeks compared to placebo. The volume of
the edema is defined as biometric data measured by the use of MRT before and six weeks after
treatment. The hypothesis has to be checked whether Zoledronic Acid is efficient in the
treatment of painful bone marrow edema. A statistically significant reduction of the edema in
the MRT is considered as evidence for efficacy.